![]() To learn more about our clinical program, please contact us here. The EGM procedure is currently being evaluated in clinical studies. Our goal is to provide patients with durable improvement in glycemic control with minimal side effects and without requiring additional daily medical therapy. ![]() The EGM procedure is being developed so that it can be performed in a standard GI endoscopy suite without requiring additional imaging equipment. Our product consists of a console and a single-use catheter that is compatible with the working channel of standard gastrointestinal endoscopes. The treatment targets the duodenal submucosa which is central to nutrient sensing and metabolic signaling. The B-Laser atherectomy system (Eximo Medical, Israel) is a 355 nm solid-state Nd:YAG short pulse laser for de-novo and restenotic infrainguinal PAD with enhanced affinity for atheroma and calcified plaque. We are developing a minimally invasive therapy, Endoscopic Glycemic Management (EGM), that aims to restore the body’s natural ability to control blood glucose levels. Studies have shown that up to 90% of patients who undergo bariatric surgery with duodenal exclusion achieve improved insulin resistance and glycemic control.ĭigma aims to harness the power of the duodenum to empower patients and physicians with safe, simple and effective new therapies for type 2 diabetes that enable them to live longer, healthier and happier lives. It was a significant milestone for us to show B-Laser’s ability to cross a highly calcified lesion using the step-by-step technique without the need to cross with a wire first in very challenging scenarios (including long and severely calcific lesions),” said Yoel Zabar, CEO of Eximo Medical.The small intestine plays a key role in regulating metabolic processes and insulin resistance. We continue to leverage the inherent advantages of our unique short pulse 355nm laser platform to develop novel techniques and expand our system’s utilization and market opportunity. “Eximo is extremely excited with the current commercial progress the B-Laser is experiencing in the competitive U.S. ![]() The B-Laser has so far been used to treat patients who have highly complex, highly calcified lesions above and below the arterial segments in the knee. I am very proud to be part of this exciting technology and journey.” “The capability to cross chronically occluded arteries without needing to cross with a wire first, and to then be able to perform atherectomy over a wire by using the same catheter represents a welcomed and significant addition to our toolkit as it addresses a real unmet need in our practice. Luis Leon, a clinician that has begun using the B-Laser system to treat patients, in a press release. I am very excited to work with Eximo using the B-Laser in a variety of PAD patients and to incorporate it routinely in our outpatient-based laboratory,” said Dr. “There is a well-known paucity of devices that allows interventionists to cross occlusive lesions in an intraluminal path as opposed to sub-intimal. Eximo’s On-Line Photo-Acoustic Signal Monitoring was also implemented for the first time during the study and showed that machine learning can help interventionists characterize materials that are in contact with catheter tips while also providing a warning signal to prevent vessel injury and procedural complications. ![]() The step-by-step crossing approach uses a standard B-Laser catheter followed by the atherectomy using the same catheter that is used with standard guidewires.ĭuring a Polish study, the B-Laser system was successful without complications, including in long and severely calcified lesions. The system was launched in a step-by-step approach for therapy in patients who have highly complex, arterial occlusive peripheral arterial disease. Eximo Medical has recently launched its B-Laser Atherectomy System for patients who have arterial occlusive peripheral arterial disease. Eximo Medical - email id & phone of top management contacts like Founder, CEO, CFO, CMO, CTO, Marketing or HR or Finance head & all company details. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |